一般合并症指标独立于FRAX对骨折风险的影响:基于注册队列研究
该回顾性队列研究纳入曼尼托巴BMD注册库(1996-2016)中年龄≥40岁的男女,使用ADG评分和近期住院次数评估合并症,随访平均9年,发现ADG评分和住院次数独立于FRAX和BMD增加骨折风险,将合并症风险比乘数应用于FRAX评分可使治疗候选者从8.6%增至14.4%。
要点
- ADG评分和住院次数独立于FRAX和BMD增加骨折风险,风险比范围1.2-1.8(所有P<0.05)。
- 应用合并症风险比乘数于FRAX评分,治疗候选者从8.6%增至14.4%(以主要骨折风险>20%为干预阈值)。
- 复杂和简单的合并症指标均可用于调整FRAX风险评估,以捕捉多种合并症相关的骨折风险增加。
核心结论
- 复杂和简单的医学合并症指标均可用于调整基于FRAX的风险估计,以捕捉老年患者多种合并症相关的骨折风险增加。
研究设计与样本
- 回顾性队列研究,纳入曼尼托巴BMD注册库(1996-2016)中年龄≥40岁的男女,要求至少3年既往医疗数据,使用链接行政数据库构建ADG评分和住院次数,平均随访9年,采用Cox回归分析。
主要发现
- ADG评分和住院次数分别独立增加所有合并症水平下的骨折风险比(风险比范围1.2-1.8,所有P<0.05),无论是否调整FRAX、BMD和竞争性死亡。
- 综合考虑时,在所有合并症增加水平下,骨折率仍高于预测值,独立于FRAX和BMD,但被竞争性死亡减弱。
- 使用主要骨折风险>20%的干预阈值,将合并症风险比乘数应用于患者人群FRAX评分,治疗候选者从8.6%增至14.4%。
关键数值与推荐
- 干预阈值:主要骨折风险>20%。
- 治疗候选者比例:应用合并症风险比乘数后从8.6%增至14.4%。
临床怎么用
- 作者认为,复杂和简单的医学合并症指标均可用于调整基于FRAX的风险估计,以捕捉老年患者多种合并症相关的骨折风险增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: FRAX® estimates 10-year fracture probability from osteoporosis-specific risk factors. Medical comorbidity indicators are associated with fracture risk but whether these are independent from those in FRAX is uncertain. OBJECTIVE: We hypothesized Johns Hopkins Aggregated Diagnosis Groups (ADG®) score or recent hospitalization number may be independently associated with increased risk for fractures. METHODS: This retrospective cohort study included women and men age ≥ 40 in the Manitoba BMD Registry (1996-2016) with at least 3 years prior health care data and used linked administrative databases to construct ADG scores along with number of hospitalizations for each individual. Incident Major Osteoporotic Fracture and Hip Fracture was ascertained during average follow-up of 9 years; Cox regression analysis determined the association between increasing ADG score or number of hospitalizations and fractures. RESULTS: Separately, hospitalizations and ADG score independently increased the hazard ratio for fracture at all levels of comorbidity (hazard range 1.2-1.8, all P < 0.05), irrespective of adjustment for FRAX, BMD, and competing mortality. Taken together, there was still a higher than predicted rate of fracture at all levels of increased comorbidity, independent of FRAX and BMD but attenuated by competing mortality. Using an intervention threshold of major fracture risk >20%, application of the comorbidity hazard ratio multiplier to the patient population FRAX scores would increase the number of treatment candidates from 8.6% to 14.4%. CONCLUSION: Both complex and simple measures of medical comorbidity may be used to modify FRAX-based risk estimates to capture the increased fracture risk associated with multiple comorbid conditions in older patients.
引用
- Kline GA, Morin SN, Lix LM, et al. General Comorbidity Indicators Contribute to Fracture Risk Independent of FRAX: Registry-Based Cohort Study. J Clin Endocrinol Metab. 2023. PMID: 36201517. doi:10.1210/clinem/dgac582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。